Clinical Trial Update: Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating vaccine therapy with or without interleukin-2 after chemotherapy and autologous white blood cell infusion in patients with metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interleukin-2 (interleukin-2)
• vaccine therapy (unspecified)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage IV Melanoma | Phase 2 | Status: TERMINATED